Patent application number | Description | Published |
20130084335 | IVABRADINE-CONTAINING PHARMACEUTICAL COMPOSITION - The present invention relates to a pharmaceutical composition containing ivabradine or a pharmaceutically acceptable salt thereof. The invention further relates to a method for the preparation of such a composition. | 04-04-2013 |
20130102682 | FINGOLIMOD IN THE FORM OF A SOLID SOLUTION - The invention relates to an intermediate containing fingolimod and matrix material, wherein the fingolimod is present in the matrix material in the form of a solid solution. The invention also relates to granules and pharmaceutical formulations containing fingolimod in the form of a solid solution in matrix material. The subject matter of the invention further relates to methods of preparing a solid solution of fingolimod or of an intermediate, and also granules and pharmaceutical formulations containing fingolimod in the form of a solid solution. | 04-25-2013 |
20130116239 | IVABRADINE-CONTAINING PHARMACEUTICAL COMPOSITION WITH MODIFIED RELEASE - The present invention relates to pharmaceutical compositions with delayed release which contain ivabradine adipate as active substance. The present invention furthermore relates to processes for the preparation of this composition and certain salts of ivabradine. | 05-09-2013 |
20130149253 | ORAL DOSAGE FORM OF PREGABALIN - The invention relates to oral dosage forms of pregabalin, preferably for the modified release, and to processes for producing it. | 06-13-2013 |
20130149346 | DABIGATRAN ETEXILATE-CONTAINING PHARMACEUTICAL COMPOSITION - The present invention relates to a pharmaceutical composition containing dabigatran etexilate or a pharmaceutically acceptable salt thereof as active ingredient. | 06-13-2013 |
20130158008 | SOLID IVABRADINE-CONTAINING COMPOSITION - The present invention relates to a solid composition containing ivabradine or a pharmaceutically acceptable salt thereof. Further, the invention relates to a method for the preparation of such a composition as well as a pharmaceutical product comprising such a composition. | 06-20-2013 |
20130224294 | DRY PROCESSING OF ATAZANAVIR - The invention relates to dry processes for producing oral dosage forms, more specifically tablets, comprising atazanavir and adhesion enhancers. The invention further relates to compacted intermediates comprising atazanavir and adhesion enhancers. | 08-29-2013 |
20140094478 | COMPOSITION AND TABLET COMPRISING RALTEGRAVIR - The present invention relates to a composition and tablet comprising raltegravir and to a process for the preparation of such tablet. | 04-03-2014 |
20140147505 | SOLID PHARMACEUTICAL DOSAGE FORM OF TICAGRELOR - The present invention relates to a solid pharmaceutical dosage form comprising ticagrelor as pharmaceutically active ingredient, to certain particles of ticagrelor and to processes of preparing the same. | 05-29-2014 |
20140357860 | SALT OF IVABRADINE WITH ADIPIC ACID - The present invention relates to pharmaceutical compositions with delayed release which contain ivabradine adipate as active substance. The present invention furthermore relates to processes for the preparation of this composition and certain salts of ivabradine. | 12-04-2014 |
20150038491 | SOLID IVABRADINE-CONTAINING COMPOSITION - The present invention relates to a solid composition containing ivabradine or a pharmaceutically acceptable salt thereof. Further, the invention relates to a method for the preparation of such a composition as well as a pharmaceutical product comprising such a composition. | 02-05-2015 |